Abstract
Vertebrate organs require locally adapted blood vessels1,2. The gain of such organotypic vessel specializations is often deemed to be molecularly unrelated to the process of organ vascularization. Here, opposing this model, we reveal a molecular mechanism for brain-specific angiogenesis that operates under the control of Wnt7a/b ligands—well-known blood–brain barrier maturation signals3–5. The control mechanism relies on Wnt7a/b-dependent expression of Mmp25, which we find is enriched in brain endothelial cells. CRISPR–Cas9 mutagenesis in zebrafish reveals that this poorly characterized glycosylphosphatidylinositol-anchored matrix metalloproteinase is selectively required in endothelial tip cells to enable their initial migration across the pial basement membrane lining the brain surface. Mechanistically, Mmp25 confers brain invasive competence by cleaving meningeal fibroblast-derived collagen IV α5/6 chains within a short non-collagenous region of the central helical part of the heterotrimer. After genetic interference with the pial basement membrane composition, the Wnt–β-catenin-dependent organotypic control of brain angiogenesis is lost, resulting in properly patterned, yet blood–brain-barrier-defective cerebrovasculatures. We reveal an organ-specific angiogenesis mechanism, shed light on tip cell mechanistic angiodiversity and thereby illustrate how organs, by imposing local constraints on angiogenic tip cells, can select vessels matching their distinctive physiological requirements.
Original language | English |
---|---|
Pages (from-to) | 863-871 |
Number of pages | 9 |
Journal | Nature |
Volume | 628 |
Issue number | 8009 |
DOIs | |
Publication status | Published - 25 Apr 2024 |
Funding
We thank C. Lopez-Otin, A. Inbal, S. Piccolo and H. Baier for sharing mutant mice and zebrafish; and P. Tebabi, T. Voet, D. Brown, M. Adam, N. Dumont and E. Dupont for assistance. The illustrations in Figs. , and and Extended Data Fig. were created using BioRender. G.S. and L.D.G. are FRIA fellows, and P.C. is a postdoctoral researcher of the FRS.-FNRS. Work in the B.V. laboratory is supported by FNRS (MIS F.4543.15), the Concerted Research Action, the Fondation ULB, the H2020 ITN \u201CBtRAIN\u201D, the Queen Elisabeth Medical Foundation, the FRFS-WELBIO (CR-2017S-05R) and the ERC (Ctrl-BBB 865176). The CMMI is supported by the European Regional Development Fund and the Walloon Region.
Funders | Funder number |
---|---|
Concerted Research Action | |
Fondation ULB | |
Région Wallonne | |
Fondation Médicale Reine Elisabeth | |
European Regional Development Fund | |
Fonds De La Recherche Scientifique - FNRS | MIS F.4543.15 |
FRFS-WELBIO | CR-2017S-05R |
European Resuscitation Council | Ctrl-BBB 865176 |
Horizon 2020 Framework Programme | 865176 |